------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Food and Drug Administration spokesman Jeff Nesbit said the agency has turned over evidence in a criminal investigation
    concerning Vitarine Pharmaceuticals Inc. to the U.S. Attorney's office in Baltimore.

Treebanked sentence:
--------------------
    Food and Drug Administration spokesman Jeff Nesbit said 0 the agency has turned over evidence in a criminal
    investigation concerning Vitarine Pharmaceuticals Inc. to the U.S. Attorney 's office in Baltimore .

Tree:
-----
    (TOP (S (NP-SBJ (NML (NML (NML (NNP Food)
                                   (CC and)
                                   (NNP Drug))
                              (NNP Administration))
                         (NN spokesman))
                    (NNP Jeff)
                    (NNP Nesbit))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ (DT the)
                                 (NN agency))
                         (VP (VBZ has)
                             (VP (VBN turned)
                                 (PRT (RP over))
                                 (NP (NN evidence))
                                 (PP-LOC (IN in)
                                         (NP (NP (DT a)
                                                 (JJ criminal)
                                                 (NN investigation))
                                             (VP (VBG concerning)
                                                 (NP (NNP Vitarine)
                                                     (NNP Pharmaceuticals)
                                                     (NNP Inc.)))))
                                 (PP-CLR (IN to)
                                         (NP (NP (NP (DT the)
                                                     (NNP U.S.)
                                                     (NNP Attorney)
                                                     (POS 's))
                                                 (NN office))
                                             (PP-LOC (IN in)
                                                     (NP (NNP Baltimore))))))))))
            (. .)))

Leaves:
-------
    0   Food
           coref: IDENT        0     0-6    Food and Drug Administration spokesman Jeff Nesbit
           coref: IDENT        1     0-3    Food and Drug Administration
           name:  ORG                0-3    Food and Drug Administration
    1   and
    2   Drug
    3   Administration
    4   spokesman
    5   Jeff
        !  name:  PERSON             5-6    Jeff Nesbit
    6   Nesbit
    7   said
           sense: say-v.1
           prop:  say.01
            v          * -> 7:0,  said
            ARG0       * -> 0:4,  Food and Drug Administration spokesman Jeff Nesbit
            ARG1       * -> 8:1,  0 the agency has turned over evidence in a criminal investigation concerning Vitarine
                                  Pharmaceuticals Inc. to the U.S. Attorney 's office in Baltimore
    8   0
    9   the
           coref: IDENT        1     9-10   the agency
    10  agency
           sense: agency-n.1
    11  has
    12  turned
           sense: turn-v.11
           prop:  turn.12
            v          * -> 12:0, turned
                         -> 13:1, over
            ARG0       * -> 9:1,  the agency
            ARG1       * -> 14:1, evidence
            ARGM-LOC   * -> 15:1, in a criminal investigation concerning Vitarine Pharmaceuticals Inc.
            ARG2       * -> 23:1, to the U.S. Attorney 's office in Baltimore
    13  over
    14  evidence
           sense: evidence-n.3
    15  in
    16  a
           coref: IDENT        3     16-18  a criminal investigation
           coref: IDENT        3     16-22  a criminal investigation concerning Vitarine Pharmaceuticals Inc.
    17  criminal
    18  investigation
           sense: investigation-n.1
    19  concerning
           sense: concern-v.1
           prop:  concern.02
            v          * -> 19:0, concerning
            ARG0       * -> 16:1, a criminal investigation
            ARG1       * -> 20:1, Vitarine Pharmaceuticals Inc.
    20  Vitarine
           coref: IDENT        5     20-22  Vitarine Pharmaceuticals Inc.
           name:  ORG                20-22  Vitarine Pharmaceuticals Inc.
    21  Pharmaceuticals
    22  Inc.
    23  to
    24  the
           coref: IDENT        6     24-28  the U.S. Attorney 's office
           coref: IDENT        6     24-30  the U.S. Attorney 's office in Baltimore
    25  U.S.
           name:  GPE                25-25  U.S.
    26  Attorney
    27  's
    28  office
           sense: office-n.5
    29  in
    30  Baltimore
           name:  GPE                30-30  Baltimore
    31  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Neither Vitarine nor any of the Springfield Gardens, N.Y., company's officials or employees have been charged with any
    crimes.

Treebanked sentence:
--------------------
    Neither Vitarine nor any of the Springfield Gardens , N.Y. , company 's officials or employees have been charged *-1
    with any crimes .

Tree:
-----
    (TOP (S (NP-SBJ-1 (DT Neither)
                      (NP (NNP Vitarine))
                      (CC nor)
                      (NP (NP (DT any))
                          (PP (IN of)
                              (NP (NP (DT the)
                                      (NML (NML (NNP Springfield)
                                                (NNP Gardens))
                                           (, ,)
                                           (NML (NNP N.Y.))
                                           (, ,))
                                      (NN company)
                                      (POS 's))
                                  (NNS officials)
                                  (CC or)
                                  (NNS employees)))))
            (VP (VBP have)
                (VP (VBN been)
                    (VP (VBN charged)
                        (NP (-NONE- *-1))
                        (PP-CLR (IN with)
                                (NP (DT any)
                                    (NNS crimes))))))
            (. .)))

Leaves:
-------
    0   Neither
    1   Vitarine
           coref: IDENT        5     1-1    Vitarine
           name:  ORG                1-1    Vitarine
    2   nor
    3   any
           coref: IDENT        11    3-3    any
           coref: IDENT        11    3-15   any of the Springfield Gardens , N.Y. , company 's officials or employees
    4   of
    5   the
           coref: IDENT        1     5-12   the Springfield Gardens , N.Y. , company 's
    6   Springfield
           name:  GPE                6-7    Springfield Gardens
    7   Gardens
    8   ,
    9   N.Y.
           name:  GPE                9-9    N.Y.
    10  ,
    11  company
           sense: company-n.1
    12  's
    13  officials
           sense: official-n.1
    14  or
    15  employees
    16  have
    17  been
    18  charged
           sense: charge-v.3
           prop:  charge.05
            v          * -> 18:0, charged
            ARG1       * -> 19:0, *-1 -> 0:1, Neither Vitarine nor any of the Springfield Gardens , N.Y. , company 's
                                              officials or employees
            ARG2       * -> 20:1, with any crimes
    19  *-1
    20  with
    21  any
    22  crimes
           sense: crime-n.1
    23  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Vitarine won approval to market a version of a blood pressure medicine but acknowledged that it substituted a SmithKline
    Beecham PLC product as its own in tests.

Treebanked sentence:
--------------------
    Vitarine won approval *PRO* to market a version of a blood pressure medicine but acknowledged that it substituted a
    SmithKline Beecham PLC product as its own in tests .

Tree:
-----
    (TOP (S (NP-SBJ (NNP Vitarine))
            (VP (VP (VBD won)
                    (NP (NN approval)
                        (S (NP-SBJ (-NONE- *PRO*))
                           (VP (TO to)
                               (VP (VB market)
                                   (NP (NP (DT a)
                                           (NN version))
                                       (PP (IN of)
                                           (NP (DT a)
                                               (NML (NN blood)
                                                    (NN pressure))
                                               (NN medicine)))))))))
                (CC but)
                (VP (VBD acknowledged)
                    (SBAR (IN that)
                          (S (NP-SBJ (PRP it))
                             (VP (VBD substituted)
                                 (NP (NP (DT a)
                                         (NML (NNP SmithKline)
                                              (NNP Beecham)
                                              (NNP PLC))
                                         (NN product)))
                                 (PP-CLR (IN as)
                                         (NP (PRP$ its)
                                             (JJ own)))
                                 (PP-LOC (IN in)
                                         (NP (NNS tests))))))))
            (. .)))

Leaves:
-------
    0   Vitarine
           coref: IDENT        5     0-0    Vitarine
           name:  ORG                0-0    Vitarine
    1   won
           sense: win-v.2
           prop:  win.01
            v          * -> 1:0,  won
            ARG0       * -> 0:1,  Vitarine
            ARG1       * -> 2:1,  approval *PRO* to market a version of a blood pressure medicine
    2   approval
           sense: approval-n.1
           prop:  approval.01
            n          * -> 2:0,  approval
            ARG1       * -> 3:2,  *PRO* to market a version of a blood pressure medicine
    3   *PRO*
    4   to
    5   market
           sense: market-v.1
           prop:  market.01
            v          * -> 5:0,  market
            ARG0       * -> 3:0,  *PRO*
            ARG1       * -> 6:2,  a version of a blood pressure medicine
            LINK-PCR   * -> 0:1,  Vitarine
                       * -> 3:0,  *PRO*
    6   a
           coref: IDENT        19    6-7    a version
           coref: IDENT        19    6-12   a version of a blood pressure medicine
    7   version
           sense: version-n.2
    8   of
    9   a
    10  blood
    11  pressure
           sense: pressure-n.1
    12  medicine
           sense: medicine-n.1
    13  but
    14  acknowledged
           sense: acknowledge-v.1
           prop:  acknowledge.01
            v          * -> 14:0, acknowledged
            ARG0       * -> 0:1,  Vitarine
            ARG1       * -> 15:1, that it substituted a SmithKline Beecham PLC product as its own in tests
    15  that
    16  it
           coref: IDENT        5     16-16  it
    17  substituted
           sense: substitute-v.1
           prop:  substitute.01
            v          * -> 17:0, substituted
            ARG0       * -> 16:1, it
            ARG1       * -> 18:2, a SmithKline Beecham PLC product
            ARG3       * -> 23:1, as its own
            ARGM-LOC   * -> 26:1, in tests
    18  a
           coref: IDENT        52    18-22  a SmithKline Beecham PLC product
    19  SmithKline
           name:  ORG                19-21  SmithKline Beecham PLC
    20  Beecham
    21  PLC
    22  product
           sense: product-n.1
    23  as
    24  its
           coref: IDENT        5     24-24  its
           coref: IDENT        32    24-25  its own
    25  own
    26  in
    27  tests
           sense: test-n.1
           coref: IDENT        26    27-27  tests
    28  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Mr. Nesbit also said the FDA has asked Bolar Pharmaceutical Co. to recall at the retail level its urinary tract
    antibiotic.

Treebanked sentence:
--------------------
    Mr. Nesbit also said 0 the FDA has asked Bolar Pharmaceutical Co. *PRO*-1 to recall at the retail level its urinary
    tract antibiotic .

Tree:
-----
    (TOP (S (NP-SBJ (NNP Mr.)
                    (NNP Nesbit))
            (ADVP (RB also))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (NP-SBJ (DT the)
                                 (NNP FDA))
                         (VP (VBZ has)
                             (VP (VBN asked)
                                 (NP-1 (NNP Bolar)
                                       (NNP Pharmaceutical)
                                       (NNP Co.))
                                 (S (NP-SBJ (-NONE- *PRO*-1))
                                    (VP (TO to)
                                        (VP (VB recall)
                                            (PP-LOC (IN at)
                                                    (NP (DT the)
                                                        (JJ retail)
                                                        (NN level)))
                                            (NP (PRP$ its)
                                                (NML (JJ urinary)
                                                     (NN tract))
                                                (NN antibiotic))))))))))
            (. .)))

Leaves:
-------
    0   Mr.
           coref: IDENT        0     0-1    Mr. Nesbit
    1   Nesbit
           name:  PERSON             1-1    Nesbit
    2   also
    3   said
           sense: say-v.1
           prop:  say.01
            v          * -> 3:0,  said
            ARG0       * -> 0:1,  Mr. Nesbit
            ARGM-DIS   * -> 2:1,  also
            ARG1       * -> 4:1,  0 the FDA has asked Bolar Pharmaceutical Co. *PRO*-1 to recall at the retail level its
                                  urinary tract antibiotic
    4   0
    5   the
           coref: IDENT        1     5-6    the FDA
    6   FDA
           name:  ORG                6-6    FDA
    7   has
    8   asked
           sense: ask-v.2
           prop:  ask.02
            v          * -> 8:0,  asked
            ARG0       * -> 5:1,  the FDA
            ARG2       * -> 9:1,  Bolar Pharmaceutical Co.
            ARG1       * -> 12:2, *PRO*-1 to recall at the retail level its urinary tract antibiotic
    9   Bolar
           coref: IDENT        29    9-11   Bolar Pharmaceutical Co.
           name:  ORG                9-11   Bolar Pharmaceutical Co.
    10  Pharmaceutical
    11  Co.
    12  *PRO*-1
    13  to
    14  recall
           sense: recall-v.2
           prop:  recall.01
            v          * -> 14:0, recall
            ARG0       * -> 12:0, *PRO*-1 -> 9:1, Bolar Pharmaceutical Co.
            ARGM-LOC   * -> 15:1, at the retail level
            ARG1       * -> 19:1, its urinary tract antibiotic
           coref: IDENT        34    14-14  recall
    15  at
    16  the
    17  retail
    18  level
           sense: level-n.2
    19  its
           coref: IDENT        29    19-19  its
           coref: IDENT        32    19-22  its urinary tract antibiotic
    20  urinary
    21  tract
           sense: tract-n.2
    22  antibiotic
    23  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    But so far the company has n't complied with that request, the spokesman said.

Treebanked sentence:
--------------------
    But so far the company has n't complied with that request , the spokesman said 0 *T*-1 .

Tree:
-----
    (TOP (S (S-TPC-1 (CC But)
                     (ADVP-TMP (RB so)
                               (RB far))
                     (NP-SBJ (DT the)
                             (NN company))
                     (VP (VBZ has)
                         (RB n't)
                         (VP (VBN complied)
                             (PP-CLR (IN with)
                                     (NP (DT that)
                                         (NN request))))))
            (, ,)
            (NP-SBJ (DT the)
                    (NN spokesman))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (-NONE- *T*-1))))
            (. .)))

Leaves:
-------
    0   But
    1   so
    2   far
    3   the
           coref: IDENT        29    3-4    the company
    4   company
           sense: company-n.1
    5   has
    6   n't
    7   complied
           sense: comply-v.1
           prop:  comply.01
            v          * -> 7:0,  complied
            ARGM-TMP   * -> 1:1,  so far
            ARG0       * -> 3:1,  the company
            ARGM-NEG   * -> 6:0,  n't
            ARG1       * -> 8:1,  with that request
    8   with
    9   that
           coref: IDENT        34    9-10   that request
    10  request
           sense: request-n.1
           prop:  request.01
            n          * -> 10:0, request
    11  ,
    12  the
           coref: IDENT        0     12-13  the spokesman
    13  spokesman
    14  said
           sense: say-v.1
           prop:  say.01
            v          * -> 14:0, said
            ARG1       * -> 16:0, *T*-1 -> 0:1, But so far the company has n't complied with that request
            ARG0       * -> 12:1, the spokesman
    15  0
    16  *T*-1
    17  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Bolar, the subject of a criminal investigation by the FDA and the Inspector General's office of the Health and Human
    Services Department, only agreed to recall two strengths of its version of Macrodantin `` as far down as direct
    customers, mostly wholesalers, '' Mr. Nesbit said.

Treebanked sentence:
--------------------
    Bolar , the subject of a criminal investigation by the FDA and the Inspector General 's office of the Health and Human
    Services Department , only agreed *PRO*-1 to recall two strengths of its version of Macrodantin `` as far down as direct
    customers , mostly wholesalers , '' Mr. Nesbit said 0 *T*-2 .

Tree:
-----
    (TOP (S (S-TPC-2 (NP-SBJ-1 (NP (NNP Bolar))
                               (, ,)
                               (NP (NP (DT the)
                                       (NN subject))
                                   (PP (IN of)
                                       (NP (NP (DT a)
                                               (JJ criminal)
                                               (NN investigation))
                                           (PP (IN by)
                                               (NP (NP (DT the)
                                                       (NNP FDA))
                                                   (CC and)
                                                   (NP (NP (NP (DT the)
                                                               (NNP Inspector)
                                                               (NNP General)
                                                               (POS 's))
                                                           (NN office))
                                                       (PP (IN of)
                                                           (NP (DT the)
                                                               (NML (NML (NNP Health))
                                                                    (CC and)
                                                                    (NML (NNP Human)
                                                                         (NNP Services)))
                                                               (NNP Department)))))))))
                               (, ,))
                     (ADVP (RB only))
                     (VP (VBD agreed)
                         (S (NP-SBJ (-NONE- *PRO*-1))
                            (VP (TO to)
                                (VP (VB recall)
                                    (NP (NP (CD two)
                                            (NNS strengths))
                                        (PP (IN of)
                                            (NP (NP (PRP$ its)
                                                    (NN version))
                                                (PP (IN of)
                                                    (NP (NNP Macrodantin))))))
                                    (`` ``)
                                    (ADVP (ADVP (RB as)
                                                (RB far)
                                                (RB down))
                                          (PP (IN as)
                                              (NP (NP (JJ direct)
                                                      (NNS customers))
                                                  (, ,)
                                                  (RB mostly)
                                                  (NP (NNS wholesalers))))))))))
            (, ,)
            ('' '')
            (NP-SBJ (NNP Mr.)
                    (NNP Nesbit))
            (VP (VBD said)
                (SBAR (-NONE- 0)
                      (S (-NONE- *T*-2))))
            (. .)))

Leaves:
-------
    0   Bolar
           coref: IDENT        29    0-24   Bolar , the subject of a criminal investigation by the FDA and the
                                            Inspector General 's office of the Health and Human Services Department ,
           coref: APPOS HEAD   37    0-0    Bolar
           name:  ORG                0-0    Bolar
    1   ,
    2   the
           coref: APPOS ATTRIB 37    2-23   the subject of a criminal investigation by the FDA and the Inspector
                                            General 's office of the Health and Human Services Department
    3   subject
           sense: subject-n.1
    4   of
    5   a
           coref: IDENT        40    5-7    a criminal investigation
           coref: IDENT        40    5-23   a criminal investigation by the FDA and the Inspector General 's office of
                                            the Health and Human Services Department
    6   criminal
    7   investigation
           sense: investigation-n.1
    8   by
    9   the
           coref: IDENT        1     9-10   the FDA
    10  FDA
           name:  ORG                10-10  FDA
    11  and
    12  the
           coref: IDENT        44    12-16  the Inspector General 's office
           coref: IDENT        44    12-23  the Inspector General 's office of the Health and Human Services
                                            Department
    13  Inspector
    14  General
    15  's
    16  office
           sense: office-n.5
    17  of
    18  the
           name:  ORG                18-23  the Health and Human Services Department
    19  Health
    20  and
    21  Human
    22  Services
    23  Department
    24  ,
    25  only
    26  agreed
           sense: agree-v.3
           prop:  agree.01
            v          * -> 26:0, agreed
            ARG0       * -> 0:2,  Bolar , the subject of a criminal investigation by the FDA and the Inspector General
                                  's office of the Health and Human Services Department ,
            ARGM-ADV   * -> 25:1, only
            ARG1       * -> 27:2, *PRO*-1 to recall two strengths of its version of Macrodantin `` as far down as direct
                                  customers , mostly wholesalers
    27  *PRO*-1
    28  to
    29  recall
           sense: recall-v.2
           prop:  recall.01
            v          * -> 29:0, recall
            ARG0       * -> 27:0, *PRO*-1 -> 0:2, Bolar , the subject of a criminal investigation by the FDA and the
                                                  Inspector General 's office of the Health and Human Services
                                                  Department ,
            ARG1       * -> 30:2, two strengths of its version of Macrodantin
                         -> 38:2, as far down as direct customers , mostly wholesalers
    30  two
           coref: IDENT        48    30-31  two strengths
           coref: IDENT        48    30-36  two strengths of its version of Macrodantin
           name:  CARDINAL           30-30  two
    31  strengths
           sense: strength-n.6
    32  of
    33  its
           coref: IDENT        29    33-33  its
           coref: IDENT        32    33-34  its version
           coref: IDENT        32    33-36  its version of Macrodantin
    34  version
           sense: version-n.2
    35  of
    36  Macrodantin
           coref: IDENT        52    36-36  Macrodantin
           name:  PRODUCT            36-36  Macrodantin
    37  ``
    38  as
    39  far
    40  down
    41  as
    42  direct
           coref: IDENT        53    42-43  direct customers
           coref: IDENT        53    42-46  direct customers , mostly wholesalers
    43  customers
    44  ,
    45  mostly
    46  wholesalers
    47  ,
    48  ''
    49  Mr.
           coref: IDENT        0     49-50  Mr. Nesbit
    50  Nesbit
           name:  PERSON             50-50  Nesbit
    51  said
           sense: say-v.1
           prop:  say.01
            v          * -> 51:0, said
            ARG1       * -> 53:0, *T*-2 -> 0:3, Bolar , the subject of a criminal investigation by the FDA and the
                                                Inspector General 's office of the Health and Human Services Department
                                                , only agreed *PRO*-1 to recall two strengths of its version of
                                                Macrodantin `` as far down as direct customers , mostly wholesalers
            ARG0       * -> 49:1, Mr. Nesbit
    52  0
    53  *T*-2
    54  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Bolar, of Copiague, N.Y., earlier began a voluntary recall of both its 100 milligram and 50 milligram versions of the
    drug.

Treebanked sentence:
--------------------
    Bolar , of Copiague , N.Y. , earlier began a voluntary recall of both its 100 milligram and 50 milligram versions of the
    drug .

Tree:
-----
    (TOP (S (NP-SBJ (NP (NNP Bolar))
                    (, ,)
                    (PP (IN of)
                        (NP (NP (NNP Copiague))
                            (, ,)
                            (NP (NNP N.Y.))
                            (, ,))))
            (ADVP-TMP (RBR earlier))
            (VP (VBD began)
                (NP (NP (DT a)
                        (JJ voluntary)
                        (NN recall))
                    (PP (IN of)
                        (NP (NP (DT both)
                                (PRP$ its)
                                (NML (NML (CD 100)
                                          (NN milligram))
                                     (CC and)
                                     (NML (CD 50)
                                          (NN milligram)))
                                (NNS versions))
                            (PP (IN of)
                                (NP (DT the)
                                    (NN drug)))))))
            (. .)))

Leaves:
-------
    0   Bolar
           coref: IDENT        29    0-0    Bolar
           coref: IDENT        29    0-6    Bolar , of Copiague , N.Y. ,
           name:  ORG                0-0    Bolar
    1   ,
    2   of
    3   Copiague
           coref: IDENT        59    3-3    Copiague
           coref: IDENT        59    3-6    Copiague , N.Y. ,
           name:  GPE                3-3    Copiague
    4   ,
    5   N.Y.
           name:  GPE                5-5    N.Y.
    6   ,
    7   earlier
    8   began
           sense: begin-v.2
           prop:  begin.01
            v          * -> 8:0,  began
            ARG0       * -> 0:2,  Bolar , of Copiague , N.Y. ,
            ARGM-TMP   * -> 7:1,  earlier
            ARG1       * -> 9:2,  a voluntary recall of both its 100 milligram and 50 milligram versions of the drug
    9   a
           coref: IDENT        62    9-11   a voluntary recall
           coref: IDENT        62    9-23   a voluntary recall of both its 100 milligram and 50 milligram versions of
                                            the drug
    10  voluntary
    11  recall
           sense: recall-n.1
           prop:  recall.01
            n          * -> 11:0, recall
            ARGM-MNR   * -> 10:0, voluntary
            ARG1       * -> 12:1, of both its 100 milligram and 50 milligram versions of the drug
    12  of
    13  both
           coref: IDENT        48    13-20  both its 100 milligram and 50 milligram versions
           coref: IDENT        48    13-23  both its 100 milligram and 50 milligram versions of the drug
    14  its
           coref: IDENT        29    14-14  its
    15  100
           name:  QUANTITY           15-16  100 milligram
    16  milligram
    17  and
    18  50
           name:  QUANTITY           18-19  50 milligram
    19  milligram
    20  versions
           sense: version-n.2
    21  of
    22  the
           coref: IDENT        52    22-23  the drug
    23  drug
           sense: drug-n.1
    24  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    The FDA has said it presented evidence it uncovered to the company indicating that Bolar substituted the brand-name
    product for its own to gain government approval to sell generic versions of Macrodantin.

Treebanked sentence:
--------------------
    The FDA has said 0 it presented evidence 0 it uncovered *T*-1 *ICH*-2 to the company indicating that Bolar substituted
    the brand - name product for its own *PRO*-3 to gain government approval *PRO* to sell generic versions of Macrodantin .

Tree:
-----
    (TOP (S (NP-SBJ (DT The)
                    (NNP FDA))
            (VP (VBZ has)
                (VP (VBD said)
                    (SBAR (-NONE- 0)
                          (S (NP-SBJ (PRP it))
                             (VP (VBD presented)
                                 (NP (NP (NN evidence))
                                     (SBAR (WHNP-1 (-NONE- 0))
                                           (S (NP-SBJ (PRP it))
                                              (VP (VBD uncovered)
                                                  (NP (-NONE- *T*-1)))))
                                     (VP (-NONE- *ICH*-2)))
                                 (PP (IN to)
                                     (NP (DT the)
                                         (NN company)))
                                 (VP-2 (VBG indicating)
                                       (SBAR (IN that)
                                             (S (NP-SBJ-3 (NNP Bolar))
                                                (VP (VBD substituted)
                                                    (NP (DT the)
                                                        (NML (NN brand)
                                                             (HYPH -)
                                                             (NN name))
                                                        (NN product))
                                                    (PP-CLR (IN for)
                                                            (NP (PRP$ its)
                                                                (JJ own)))
                                                    (S-PRP (NP-SBJ (-NONE- *PRO*-3))
                                                           (VP (TO to)
                                                               (VP (VB gain)
                                                                   (NP (NN government)
                                                                       (NN approval)
                                                                       (S (NP-SBJ (-NONE- *PRO*))
                                                                          (VP (TO to)
                                                                              (VP (VB sell)
                                                                                  (NP (NP (JJ generic)
                                                                                          (NNS versions))
                                                                                      (PP (IN of)
                                                                                          (NP (NNP
    Macrodantin))))))))))))))))))))
            (. .)))

Leaves:
-------
    0   The
           coref: IDENT        1     0-1    The FDA
    1   FDA
           name:  ORG                1-1    FDA
    2   has
    3   said
           sense: say-v.1
           prop:  say.01
            v          * -> 3:0,  said
            ARG0       * -> 0:1,  The FDA
            ARG1       * -> 4:1,  0 it presented evidence 0 it uncovered *T*-1 *ICH*-2 to the company indicating that
                                  Bolar substituted the brand - name product for its own *PRO*-3 to gain government
                                  approval *PRO* to sell generic versions of Macrodantin
                         -> 16:1, indicating that Bolar substituted the brand - name product for its own *PRO*-3 to gain
                                  government approval *PRO* to sell generic versions of Macrodantin
                       * -> 12:0, *ICH*-2 -> 16:1, indicating that Bolar substituted the brand - name product for its
                                                   own *PRO*-3 to gain government approval *PRO* to sell generic
                                                   versions of Macrodantin
    4   0
    5   it
           coref: IDENT        1     5-5    it
    6   presented
           sense: present-v.2
           prop:  present.01
            v          * -> 6:0,  presented
            ARG0       * -> 5:1,  it
            ARG1       * -> 7:2,  evidence 0 it uncovered *T*-1 *ICH*-2
                         -> 16:1, indicating that Bolar substituted the brand - name product for its own *PRO*-3 to gain
                                  government approval *PRO* to sell generic versions of Macrodantin
                       * -> 12:0, *ICH*-2 -> 16:1, indicating that Bolar substituted the brand - name product for its
                                                   own *PRO*-3 to gain government approval *PRO* to sell generic
                                                   versions of Macrodantin
            ARG2       * -> 13:1, to the company
    7   evidence
           sense: evidence-n.1
           coref: IDENT        69    7-7    evidence
           coref: IDENT        69    7-12   evidence 0 it uncovered *T*-1 *ICH*-2
    8   0
    9   it
           coref: IDENT        1     9-9    it
    10  uncovered
           sense: uncover-v.1
           prop:  uncover.01
            v          * -> 10:0, uncovered
            ARG1       * -> 11:0, *T*-1 -> 8:0, 0
            ARG0       * -> 9:1,  it
            LINK-PCR   * -> 7:1,  evidence
                       * -> 8:0,  0
                       * -> 11:0, *T*-1 -> 8:0, 0
    11  *T*-1
    12  *ICH*-2
    13  to
    14  the
           coref: IDENT        29    14-15  the company
    15  company
           sense: company-n.1
    16  indicating
           sense: indicate-v.1
           prop:  indicate.01
            v          * -> 16:0, indicating
            ARG0       * -> 7:2,  evidence 0 it uncovered *T*-1 *ICH*-2
                         -> 16:1, indicating that Bolar substituted the brand - name product for its own *PRO*-3 to gain
                                  government approval *PRO* to sell generic versions of Macrodantin
                       * -> 12:0, *ICH*-2 -> 16:1, indicating that Bolar substituted the brand - name product for its
                                                   own *PRO*-3 to gain government approval *PRO* to sell generic
                                                   versions of Macrodantin
            ARG1       * -> 17:1, that Bolar substituted the brand - name product for its own *PRO*-3 to gain government
                                  approval *PRO* to sell generic versions of Macrodantin
    17  that
    18  Bolar
           coref: IDENT        29    18-18  Bolar
           name:  ORG                18-18  Bolar
    19  substituted
           sense: substitute-v.1
           prop:  substitute.01
            v          * -> 19:0, substituted
            ARG0       * -> 28:0, *PRO*-3 -> 18:1, Bolar
            ARG1       * -> 20:1, the brand - name product
            ARG3       * -> 25:1, for its own
            ARGM-PNC   * -> 28:2, *PRO*-3 to gain government approval *PRO* to sell generic versions of Macrodantin
    20  the
           coref: IDENT        52    20-24  the brand - name product
    21  brand
    22  -
    23  name
    24  product
           sense: product-n.1
    25  for
    26  its
           coref: IDENT        29    26-26  its
           coref: IDENT        32    26-27  its own
    27  own
    28  *PRO*-3
    29  to
    30  gain
           sense: gain-v.1
           prop:  gain.02
            v          * -> 30:0, gain
            ARG0       * -> 28:0, *PRO*-3 -> 18:1, Bolar
            ARG1       * -> 31:1, government approval *PRO* to sell generic versions of Macrodantin
    31  government
    32  approval
    33  *PRO*
    34  to
    35  sell
           sense: sell-v.1
           prop:  sell.01
            v          * -> 35:0, sell
            ARG0       * -> 33:0, *PRO*
            ARG1       * -> 36:2, generic versions of Macrodantin
            LINK-PCR   * -> 18:1, Bolar
                       * -> 33:0, *PRO*
    36  generic
           coref: IDENT        80    36-37  generic versions
           coref: IDENT        80    36-39  generic versions of Macrodantin
    37  versions
           sense: version-n.2
    38  of
    39  Macrodantin
           coref: IDENT        52    39-39  Macrodantin
           name:  PRODUCT            39-39  Macrodantin
    40  .


------------------------------------------------------------------------------------------------------------------------

Plain sentence:
---------------
    Bolar has denied that it switched the brand-name product for its own in such testing.

Treebanked sentence:
--------------------
    Bolar has denied that it switched the brand - name product for its own in such testing .

Tree:
-----
    (TOP (S (NP-SBJ (NNP Bolar))
            (VP (VBZ has)
                (VP (VBN denied)
                    (SBAR (IN that)
                          (S (NP-SBJ (PRP it))
                             (VP (VBD switched)
                                 (NP (DT the)
                                     (NML (NN brand)
                                          (HYPH -)
                                          (NN name))
                                     (NN product))
                                 (PP-CLR (IN for)
                                         (NP (PRP$ its)
                                             (JJ own)))
                                 (PP-LOC (IN in)
                                         (NP (JJ such)
                                             (NN testing))))))))
            (. .)))

Leaves:
-------
    0   Bolar
           coref: IDENT        29    0-0    Bolar
           name:  ORG                0-0    Bolar
    1   has
    2   denied
           sense: deny-v.1
           prop:  deny.01
            v          * -> 2:0,  denied
            ARG0       * -> 0:1,  Bolar
            ARG1       * -> 3:1,  that it switched the brand - name product for its own in such testing
    3   that
    4   it
           coref: IDENT        29    4-4    it
    5   switched
           sense: switch-v.2
           prop:  switch.01
            v          * -> 5:0,  switched
            ARG0       * -> 4:1,  it
            ARG1       * -> 6:1,  the brand - name product
            ARG2       * -> 11:1, for its own
            ARGM-LOC   * -> 14:1, in such testing
    6   the
           coref: IDENT        52    6-10   the brand - name product
    7   brand
    8   -
    9   name
    10  product
           sense: product-n.1
    11  for
    12  its
           coref: IDENT        29    12-12  its
           coref: IDENT        32    12-13  its own
    13  own
    14  in
    15  such
           coref: IDENT        26    15-16  such testing
    16  testing
           sense: test-n.1
    17  .


========================================================================================================================
Coreference chains for section 0:
---------------------------------

    Chain 0 (IDENT)
               0.0-6      Food and Drug Administration spokesman Jeff Nesbit
               3.0-1      Mr. Nesbit
               4.12-13    the spokesman
               5.49-50    Mr. Nesbit

    Chain 1 (IDENT)
               0.0-3      Food and Drug Administration
               0.9-10     the agency
               1.5-12     the Springfield Gardens , N.Y. , company 's
               3.5-6      the FDA
               5.9-10     the FDA
               7.0-1      The FDA
               7.5-5      it
               7.9-9      it

    Chain 3 (IDENT)
               0.16-18    a criminal investigation
               0.16-22    a criminal investigation concerning Vitarine Pharmaceuticals Inc.

    Chain 5 (IDENT)
               0.20-22    Vitarine Pharmaceuticals Inc.
               1.1-1      Vitarine
               2.0-0      Vitarine
               2.16-16    it
               2.24-24    its

    Chain 6 (IDENT)
               0.24-28    the U.S. Attorney 's office
               0.24-30    the U.S. Attorney 's office in Baltimore

    Chain 11 (IDENT)
               1.3-3      any
               1.3-15     any of the Springfield Gardens , N.Y. , company 's officials or employees

    Chain 19 (IDENT)
               2.6-7      a version
               2.6-12     a version of a blood pressure medicine

    Chain 52 (IDENT)
               2.18-22    a SmithKline Beecham PLC product
               5.36-36    Macrodantin
               6.22-23    the drug
               7.20-24    the brand - name product
               7.39-39    Macrodantin
               8.6-10     the brand - name product

    Chain 32 (IDENT)
               2.24-25    its own
               3.19-22    its urinary tract antibiotic
               5.33-34    its version
               5.33-36    its version of Macrodantin
               7.26-27    its own
               8.12-13    its own

    Chain 26 (IDENT)
               2.27-27    tests
               8.15-16    such testing

    Chain 29 (IDENT)
               3.9-11     Bolar Pharmaceutical Co.
               3.19-19    its
               4.3-4      the company
               5.0-24     Bolar , the subject of a criminal investigation by the FDA and the Inspector General 's office
                          of the Health and Human Services Department ,
               5.33-33    its
               6.0-0      Bolar
               6.0-6      Bolar , of Copiague , N.Y. ,
               6.14-14    its
               7.14-15    the company
               7.18-18    Bolar
               7.26-26    its
               8.0-0      Bolar
               8.4-4      it
               8.12-12    its

    Chain 34 (IDENT)
               3.14-14    recall
               4.9-10     that request

    Chain 37 (APPOS)
        HEAD   5.0-0      Bolar
        ATTRIB 5.2-23     the subject of a criminal investigation by the FDA and the Inspector General 's office of the
                          Health and Human Services Department

    Chain 40 (IDENT)
               5.5-7      a criminal investigation
               5.5-23     a criminal investigation by the FDA and the Inspector General 's office of the Health and
                          Human Services Department

    Chain 44 (IDENT)
               5.12-16    the Inspector General 's office
               5.12-23    the Inspector General 's office of the Health and Human Services Department

    Chain 48 (IDENT)
               5.30-31    two strengths
               5.30-36    two strengths of its version of Macrodantin
               6.13-20    both its 100 milligram and 50 milligram versions
               6.13-23    both its 100 milligram and 50 milligram versions of the drug

    Chain 53 (IDENT)
               5.42-43    direct customers
               5.42-46    direct customers , mostly wholesalers

    Chain 59 (IDENT)
               6.3-3      Copiague
               6.3-6      Copiague , N.Y. ,

    Chain 62 (IDENT)
               6.9-11     a voluntary recall
               6.9-23     a voluntary recall of both its 100 milligram and 50 milligram versions of the drug

    Chain 69 (IDENT)
               7.7-7      evidence
               7.7-12     evidence 0 it uncovered *T*-1 *ICH*-2

    Chain 80 (IDENT)
               7.36-37    generic versions
               7.36-39    generic versions of Macrodantin
